Loading organizations...
Zhonghai Shengrong Capital operates as an asset management firm, deploying capital across diverse sectors within China. The firm specializes in strategic investments and private equity, targeting companies in media, entertainment, internet services, manufacturing, healthcare, financial services, information technology, and logistics. It actively identifies and nurtures growth opportunities to generate long-term value through financial backing.
Established in 2011, Zhonghai Shengrong Capital is predominantly owned by Zhonghai Shengrong (Beijing) Capital Management Limited Company, ultimately linked to Xie Zhikun, founder of the Zhongzhi Enterprise Group. Its formation aimed to formalize and expand asset management operations, leveraging understanding of China's evolving industrial and financial landscapes.
The firm partners with various companies, becoming a strategic shareholder to facilitate their development and transformation. Zhonghai Shengrong Capital aims to establish sustainable business ecosystems, enhancing the strategic value of its portfolio companies. Its long-term vision centers on leveraging investment acumen to drive industrial upgrades and foster innovation.
Zhonghai Shengrong Capital has 2 tracked investments across 2 companies. The latest tracked deal is $15.7M Series C in Fanzhi Medicine in January 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 30, 2022 | Fanzhi Medicine | $15.7M Series C | — | Goldensand Capital |
| Sep 28, 2017 | Royole Corporation | $800.0M Debt / Series D | — | Agricultural Bank OF China, Bank OF China, China CITIC Bank, Hanfor Capital, Industrial And Commercial Bank OF China, Ping AN, SPD Bank, Tanshi Capital, Warmsun Holding Group |
